Trial Details
Not recruitingBasic Information
| Clinical ID | c2659 |
|---|---|
| Identifier | NCT03945019 |
| Trial Title | A Randomized, Placebo-Controlled, Double-Blind, Phase 3 Study to Evaluate the Efficacy and Safety of the Subcutaneous Injection of CT-P13 (CT-P13 SC) as Maintenance Therapy in Patients With Moderately to Severely Active Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | No results available |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | Biological: CT-P13 SC (Infliximab);Other: Placebo SC |
Participant Information
| Sponsor | Celltrion |
|---|---|
| City | - |
| Country/Region | Poland;United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | Interventional |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2025-04-24 |
|---|---|
| Primary Completion Date | - |
| Completion Date | - |